Lin, T., Al-Makki, A. and Shepler, B. (2022) “Tenapanor: A new treatment option for hyperphosphatemia in end stage kidney disease”, Journal of Pharmacy & Pharmaceutical Sciences, 25, pp. 77–83. doi: 10.18433/jpps32284.